Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Steroid Biochemistry and Molecular Biology

• Publication date

  1995-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0960-0760(95)00214-6PMID 8541236
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estrogen action on hepatic synthesis of angiotensinogen and IGF-I: direct and indirect estrogen effects.

  1994cited by this paper
• Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17 beta-estradiol.

  1993cited by this paper
• Steroid sulfation Current concepts.

  1993cited by this paper
• Hormone replacement therapy and cardiovascular disease.

  1993cited by this paper
• Oral versus transdermal hormone replacement therapy.

  1993cited by this paper
• Pharmacokinetics of oral 17 beta-estradiol.

  1992cited by this paper
• Pharmacokinetics of oral 17 beta-estradiol.

  1992cited by this paper
• Regulation of hepatic angiotensinogen synthesis and secretion by steroid hormones.

  1992cited by this paper
• Glucocorticoid- and estrogen-responsive elements in the 5'-flanking region of the rat angiotensinogen gene.

  1991cited by this paper
• Selected aspects of the pharmacokinetics and metabolism of ethinyl estrogens and their clinical implications.

  1990cited by this paper
• Comparison of serum ethinyl estradiol, sex-hormone-binding globulin, corticoid-binding globulin and cortisol levels in women using two low-dose combined oral contraceptives.

  1990cited by this paper
• Estrogen therapy and liver function—metabolic effects of oral and parenteral administration

  1989cited by this paper
• Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol.

  1985cited by this paper
• Steroid sulphatase inhibitors: A new endocrine therapy

  1984cited by this paper
• Antagonistic action of estrogens, flutamide, and human growth hormone on androgen-induced changes in the activities of some enzymes of hepatic steroid metabolism in the rat.

  1983cited by this paper
• Comparison of pharmacodynamic properties of various estrogen formulations.

  1982cited by this paper
• Time-studies of the changes in the sex-dependent activities of enzymes of hepatic steroid metabolism in the rat during oestrogen administration.

  1979cited by this paper
• [Steroids. 15. Sulfonyloxy derivatives of estrogens].

  1975cited by this paper
• Estrogen Receptors in Target Tissues

  1966cited by this paper
• The effect of the administration of estrogens on the renin-substrate (hypertensinogen) content of rat plasma.

  1952cited by this paper

• Dual targeting carbonic anhydrase inhibitors as promising therapeutic approach: a structural overview

  2025cites this paper
• Design, structure-activity relationships, and enzyme kinetic studies of tricyclic and tetracyclic coumarin-based sulfamates as steroid sulfatase inhibitors.

  2023cites this paper
• Potential anti-amoebic activity of sulfonate- and sulfamate-containing carboxamide derivatives against pathogenic Acanthamoeba castellanii belonging to the genotype T4.

  2023cites this paper
• Synthesis and biological activities of flavonoid sulfamates as steroid sulfatase inhibitors

  2023cites this paper
• 2‐Difluoromethoxy‐Substituted Estratriene Sulfamates: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Steroid Sulfatase Inhibition

  2022cites this paper
• The Design, Structure-Activity, and kinetic studies of 3-Benzyl-5-oxa-1,2,3,4-Tetrahydro-2H-chromeno-(3,4-c)pyridin-8-yl sulfamates as Steroid sulfatase inhibitors.

  2022cites this paper
• Transition metal-catalysed A-ring C–H activations and C(sp2)–C(sp2) couplings in the 13α-oestrone series and in vitro evaluation of antiproliferative properties

  2021cites this paper
• University of Birmingham Steroid sulphatase and its inhibitors

  2021cites this paper
• Steroid Sulphatase and Its Inhibitors: Past, Present, and Future

  2021cites this paper
• Recent progress in the development of steroid sulphatase inhibitors – examples of the novel and most promising compounds from the last decade

  2020cites this paper
• Identification of zebrafish steroid sulfatase and comparative analysis of the enzymatic properties with human steroid sulfatase.

  2019cites this paper
• Tetrahydroisoquinoline Sulfamates as Potent Microtubule Disruptors: Synthesis, Antiproliferative and Antitubulin Activity of Dichlorobenzyl-Based Derivatives, and a Tubulin Cocrystal Structure

  2019cites this paper
• Modes of cell death induced by tetrahydroisoquinoline-based analogs in MDA-MB-231 breast and A549 lung cancer cell lines

  2018cites this paper
• SULFATION PATHWAYS: Steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects.

  2018cites this paper
• Sterilization of Silastic Capsules Containing 17β-Estradiol for Effective Hormone Delivery in Mus musculus.

  2018cites this paper
• Steroid Sulfatase Inhibition via Aryl Sulfamates: Clinical Progress, Mechanism and Future Prospects

  2018cites this paper
• Modes of cell death induced by tetrahydroisoquinoline-based analogs in MDa-MB-231 breast and a549 lung cancer cell lines

  2018cites this paper
• Challenging medicinal chemistry: ups and downs in a drug discovery project

  2018cites this paper
• Estradiol prodrugs (EP) for efficient oral estrogen treatment and abolished effects on estrogen modulated liver functions.

  2017cites this paper
• Improving breast cancer therapy through oestrone analogue and glycolysis inhibitor synergism

  2017cites this paper
• A prodrug design for improved oral absorption and reduced hepatic interaction.

  2017cites this paper
• Design, synthesis, and biological evaluation of new arylamide derivatives possessing sulfonate or sulfamate moieties as steroid sulfatase enzyme inhibitors

  2016cites this paper
• Synthesis and steroid sulfatase inhibitory activities of N-phosphorylated 3-(4-aminophenyl)-coumarin-7-O-sulfamates

  2016cites this paper
• Autophagy induced by a sulphamoylated estrone analogue contributes to its cytotoxic effect on breast cancer cells

  2016cites this paper
• Exploiting drug synergism to extend the application of oestrone analogues

  2016cites this paper
• Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.

  2015cites this paper
• Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential.

  2015cites this paper
• Novel in silico-designed estradiol analogues are cytotoxic to a multidrug-resistant cell line at nanomolar concentrations

  2015cites this paper
• Chapter 28 – Designing Prodrugs and Bioprecursors

  2015cites this paper
• Synthesis of bicoumarin thiophosphate derivatives as steroid sulfatase inhibitors.

  2015cites this paper
• Characterization and Regulation of Steroid Sulfatase in the Human MG-63 Pre-osteoblastic Cell Line

  2015cites this paper
• Synthesis and Cytotoxic Activity of Pentacyclic Triterpenoid Sulfamates

  2015cites this paper
• O-(Aminosulfonylation) of phenols and an example of slow hydrolytic release

  2014cites this paper
• Tetrahydroisoquinolinone‐Based Steroidomimetic and Chimeric Microtubule Disruptors

  2014cites this paper
• Steroid sulfatase mediated growth Sof human MG-63 pre-osteoblastic cells.

  2014cites this paper
• Synthesis, Antitubulin, and Antiproliferative SAR of C3/C1‐Substituted Tetrahydroisoquinolines

  2014cites this paper
• Molecular crosstalk between apoptosis and autophagy induced by a novel 2-methoxyestradiol analogue in cervical adenocarcinoma cells

  2013cites this paper
• Investigation of a tetrahydroisoquinoline scaffold as dual-action steroid sulfatase inhibitors generated by parallel solid-phase synthesis

  2013cites this paper
• Sulphamoylated 2-Methoxyestradiol Analogues Induce Apoptosis in Adenocarcinoma Cell Lines

  2013cites this paper
• Phase Two Steroid Metabolism and Its Roles in Breast and Prostate Cancer Patients

  2013cites this paper
• Sulfatase inhibitors: a patent review

  2013cites this paper
• Steroid derivatives as inhibitors of steroid sulfatase.

  2013cites this paper
• Approaches for Searching of Modified Steroid Estrogen Analogues with Improved Biological Properties

  2012cites this paper
• In Vitro Evaluation of ESE-15-ol, an Estradiol Analogue with Nanomolar Antimitotic and Carbonic Anhydrase Inhibitory Activity

  2012cites this paper
• Hormonal enzymatic systems in normal and cancerous human breast: control, prognostic factors, and clinical applications

  2012cites this paper
• Nouveaux promédicaments de médicaments phénoliques

  2012cites this paper
• Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?

  2012cites this paper
• Estudio farmacocinético preclínico de un inhibidor de la sulfatasa esteroidal

  2012cites this paper
• Molecular crosstalk between apoptosis and autophagy induced by a 2-methoxyestradiol analogue (C19) in HeLa cells

  2012cites this paper
• Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.

  2012cites this paper
• Docking, Synthesis, and in vitro Evaluation of Antimitotic Estrone Analogs

  2011influential citation
• Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agents.

  2011cites this paper
• Endocrine therapy after aromatase inhibitor therapy in breast cancer

  2011cites this paper
• Characterization of Carbonic Anhydrase Isozyme Specific Inhibition by Sulfamated 2-Ethylestra Compounds

  2011cites this paper
• In vitro effects of an in silico‐modelled 17β‐estradiol derivative in combination with dichloroacetic acid on MCF‐7 and MCF‐12A cells

  2011cites this paper
• Inhibition of steroid sulfatase decreases endometriosis in an in vivo murine model.

  2011cites this paper
• Prodrug design of phenolic drugs.

  2010cites this paper
• Structures of human carbonic anhydrase II/inhibitor complexes reveal a second binding site for steroidal and nonsteroidal inhibitors.

  2010cites this paper
• Effect of Steroids and Sulfated Steroids on Growth of the Human MG-63 Osteoblast-like Cell Line.

  2010cites this paper
• Human Steroid Sulfatase: Inhibitor Studies and Photoaffinity Labeling

  2010cites this paper
• The Enzymatic Systems in the Formation and Transformation of Estrogens in Normal and Cancerous Human Breast: Control and Potential Clinical Applications

  2008cites this paper
• Inactivation of recombinant human steroid sulfatase by KW-2581.

  2008cites this paper
• Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling.

  2008cites this paper
• Effects of mutations and glycosylations on STS activity: a site-directed mutagenesis study.

  2008cites this paper
• Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents.

  2008cites this paper
• Kinetic and mechanistic studies of the hydrolysis of sulfamate esters: a non-elimination decomposition route

  2008cites this paper
• Designing Prodrugs and Bioprecursors

  2008cites this paper
• Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography

  2008influential citation
• Advances in hormone replacement therapy: Weight benefits of drospirenone, a 17α-spirolactone-derived progestogen

  2007cites this paper
• In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol

  2007cites this paper
• A Case for Prodrugs

  2007cites this paper
• Thiosemicarbazones of formyl benzoic acids as novel potent inhibitors of estrone sulfatase.

  2007cites this paper
• Prodrugs of Alcohols and Phenols

  2007cites this paper
• A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer

  2007cites this paper
• Prodrugs to Reduce Presystemic Metabolism

  2007cites this paper
• Prodrug Strategies for Improving Drug-Like Properties

  2006cites this paper
• Effects of stable transfection of human fetal osteoblast cells with estrogen receptor-alpha on regulation of gene expression by tibolone.

  2006cites this paper
• 2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity.

  2006cites this paper
• Kinetic and mechanistic studies on sulfamate esters: models of enzyme inhibitors†

  2006cites this paper
• Inhibition of estrone sulfatase by aromatase inhibitor-based estrogen 3-sulfamates.

  2006cites this paper
• Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.

  2005cites this paper
• Steroid sulfatase: molecular biology, regulation, and inhibition.

  2005cites this paper
• Steroid sulfatase inhibitors

  2005cites this paper
• A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agents.

  2005cites this paper
• Sulfamates and their therapeutic potential

  2005cites this paper
• Development of novel steroid sulfatase inhibitors; II. TZS-8478 potently inhibits the growth of breast tumors in postmenopausal breast cancer model rats.

  2004cites this paper
• Pharmacokinetics of the nonsteroidal steroid sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in rats

  2004cites this paper
• The selective estrogen enzyme modulators in breast cancer: a review.

  2004cites this paper
• Stilbene‐Based Inhibitors of Estrone Sulfatase with a Dual Mode of Action in Human Breast Cancer Cells

  2004cites this paper
• The role of steroid sulphatase in regulating the oestrogenicity of oestrogen sulphamates.

  2004cites this paper
• 2-(1-adamantyl)-4-(thio)chromenone-6-carboxylic acids: potent reversible inhibitors of human steroid sulfatase.

  2004cites this paper
• Therapeutic applications of sulfamates

  2004cites this paper
• 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.

  2004cites this paper
• Inhibition of in vitro angiogenesis by 2‐methoxy‐ and 2‐ethyl‐estrogen sulfamates

  2004cites this paper
• Role of enzymes and tissue-specific actions of steroids.

  2004cites this paper
• Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents

  2004cites this paper
• 3β-Sulfamate Derivatives of C19 and C21 Steroids Bearing a t -Butylbenzyl or a Benzyl Group: Synthesis and Evaluation as Non-estrogenic and Non-androgenic Steroid Sulfatase Inhibitors

  2003cites this paper
• Development of novel steroid sulfatase inhibitors. I. Synthesis and biological evaluation of biphenyl-4-O-sulfamates.

  2003cites this paper
• Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate.

  2003cites this paper
• Development of a sensitive high-performance liquid chromatography method for the detection of 667 COUMATE in vivo.

  2003cites this paper